ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China
· Delayed Price · Currency is CNY 11.01
-0.06 (-0.54%)
Apr 30, 2026, 3:00 PM CST
SHA:600479 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,449 | 5,001 | 4,528 | 4,619 | 4,126 | 5,252 | Upgrade
|
| Market Cap Growth | 22.86% | 10.44% | -1.97% | 11.96% | -21.44% | 45.26% | Upgrade
|
| Enterprise Value | 5,090 | 5,232 | 3,517 | 3,642 | 3,342 | 4,650 | Upgrade
|
| Last Close Price | 11.07 | 10.16 | 10.34 | 10.07 | 8.70 | 10.74 | Upgrade
|
| PE Ratio | 16.66 | 17.47 | 19.62 | 14.42 | 13.64 | 17.39 | Upgrade
|
| Forward PE | - | 13.60 | 13.60 | 13.60 | 13.60 | 13.60 | Upgrade
|
| PS Ratio | 1.50 | 1.38 | 1.25 | 1.22 | 1.02 | 1.43 | Upgrade
|
| PB Ratio | 1.63 | 1.49 | 1.44 | 1.53 | 1.47 | 1.95 | Upgrade
|
| P/TBV Ratio | 1.96 | 1.80 | 2.02 | 2.13 | 2.06 | 2.72 | Upgrade
|
| P/FCF Ratio | 15.30 | 14.04 | 12.89 | 11.57 | 5.90 | 12.70 | Upgrade
|
| P/OCF Ratio | 11.35 | 10.41 | 11.36 | 10.43 | 5.63 | 10.82 | Upgrade
|
| PEG Ratio | - | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | Upgrade
|
| EV/Sales Ratio | 1.40 | 1.44 | 0.97 | 0.96 | 0.83 | 1.27 | Upgrade
|
| EV/EBITDA Ratio | 10.55 | 11.47 | 9.64 | 7.97 | 7.05 | 11.10 | Upgrade
|
| EV/EBIT Ratio | 13.47 | 13.85 | 12.19 | 9.68 | 8.26 | 13.11 | Upgrade
|
| EV/FCF Ratio | 14.29 | 14.69 | 10.01 | 9.13 | 4.78 | 11.24 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.04 | 0.04 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.21 | 0.15 | 0.24 | 0.25 | 0.34 | Upgrade
|
| Debt / FCF Ratio | 0.28 | 0.28 | 0.17 | 0.29 | 0.18 | 0.36 | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.20 | -0.41 | -0.62 | -0.63 | -0.47 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.49 | -1.49 | -3.54 | -4.11 | -3.78 | -3.04 | Upgrade
|
| Net Debt / FCF Ratio | -1.91 | -1.91 | -3.67 | -4.71 | -2.56 | -3.08 | Upgrade
|
| Asset Turnover | 0.76 | 0.76 | 0.79 | 0.82 | 0.93 | 0.88 | Upgrade
|
| Inventory Turnover | 3.81 | 3.81 | 3.83 | 3.62 | 4.00 | 3.90 | Upgrade
|
| Quick Ratio | 1.09 | 1.09 | 1.64 | 1.91 | 1.64 | 1.86 | Upgrade
|
| Current Ratio | 1.45 | 1.45 | 2.05 | 2.28 | 2.07 | 2.38 | Upgrade
|
| Return on Equity (ROE) | 11.58% | 11.58% | 9.82% | 13.52% | 14.04% | 13.72% | Upgrade
|
| Return on Assets (ROA) | 4.96% | 4.96% | 3.91% | 5.05% | 5.82% | 5.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.07% | 14.44% | 17.40% | 29.72% | 28.64% | 21.62% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.90% | 10.90% | 9.00% | 12.00% | 13.80% | 12.50% | Upgrade
|
| Earnings Yield | 5.25% | 5.73% | 5.10% | 6.94% | 7.33% | 5.75% | Upgrade
|
| FCF Yield | 6.54% | 7.12% | 7.76% | 8.64% | 16.94% | 7.88% | Upgrade
|
| Dividend Yield | 3.40% | - | 3.48% | 3.48% | 4.02% | 5.59% | Upgrade
|
| Payout Ratio | 53.33% | 53.33% | 66.22% | 46.16% | 82.19% | 142.20% | Upgrade
|
| Buyback Yield / Dilution | -4.15% | -4.15% | 2.11% | 1.31% | -2.30% | 0.01% | Upgrade
|
| Total Shareholder Return | -0.75% | -4.15% | 5.59% | 4.78% | 1.72% | 5.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.